Scarica l'app Stockscreener
31.32
2.74%
0.7502
Ideaya Biosciences Inc Borsa (IDYA) Ultime notizie
Responsive Playbooks and the IDYA Inflection - Stock Traders Daily
IDEAYA Biosciences enrolls first patient in IDE892 Phase 1/2 trial - grafa.com
Why is Ideaya Biosciences stock rallying today? By Investing.com - Investing.com Canada
Ideaya Biosciences stock rises on phase 1/2 cancer trial start By Investing.com - Investing.com South Africa
Ideaya begins trial of IDE892 combo in lung, pancreatic cancer - Investing.com
IDEAYA Biosciences, Inc. (IDYA) Latest Stock News & Headlines - Yahoo Finance
New drug combo targets MTAP-deleted pancreatic and lung cancers - Stock Titan
IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - GuruFocus
Wedbush Maintains IDEAYA Biosciences(IDYA.US) With Buy Rating, Maintains Target Price $58 - Moomoo
IDEAYA Biosciences, Inc. (IDYA) reports Q1 loss, misses revenue estimates - MSN
IDEAYA files shelf offering to raise up to $300M - MSN
Ideaya Biosciences (IDYA) Forms Clinical Partnership With Roche for IDE892 Efficacy Study - Insider Monkey
IDEAYA Biosciences: 'Strong Buy' On Darovasertib NDA Filing Submission Completion H2 2026 - Seeking Alpha
Ideaya Biosciences Stock Crashes 10% Despite Citizens Reiterating Highly Bullish Price Target on Oncology Pipeline - TIKR.com
IDEAYA Biosciences prices $300M public offering of shares and pre-funded warrants at $27/share - MSN
IDEAYA Announces Closing of Public Offering Including Full Exerc - GuruFocus
IDEAYA Biosciences closes $345M public offering By Investing.com - Investing.com South Africa
IDEAYA Biosciences closes $345M public offering - Investing.com
IDEAYA Biosciences raises $323.6M in follow-on offering of common stock and pre-funded warrants - TradingView
IDEAYA Biosciences (NASDAQ: IDYA) raises $323.6M via stock and pre-funded warrants - Stock Titan
IDEAYA Announces Closing of Public Offering Including Full Exercise of Underwriters' Option to Purchase Additional Shares - PR Newswire
5 Best AI Driven Biotech Stocks to Invest In - Insider Monkey
IDEAYA (NASDAQ: IDYA) raises ~$281M via 5.56M shares and pre-funded warrants - Stock Titan
UBS Maintains IDEAYA Biosciences(IDYA.US) With Buy Rating, Maintains Target Price $50 - Moomoo
Update: IDEAYA Shares Fall After Pricing $300 Million Offering - Moomoo
Peninsula company lines up $345 million stock deal targeting eye cancer - The Business Journals
Mission Produce Posts Downbeat Q2 Earnings, Joins Ideaya Biosciences, Perrigo And Other Big Stocks Moving - Benzinga
Ideaya: Expect Offering to Close on or About June 10 >IDYA - Moomoo
Citizens reiterates Ideaya Biosciences stock rating on ASCO data By Investing.com - Investing.com Canada
IDEAYA Biosciences prices $300 million stock offering By Investing.com - Investing.com Australia
IDEAYA Biosciences prices $300 million stock offering - Investing.com UK
IDEAYA sets $27 price in $300M stock and warrant sale to investors - Stock Titan
IDEAYA Announces Pricing of $300 Million Offering of Common Stock and Pre-Funded Warrants - Financial Times
IDEAYA Announces Proposed Public Offering of Common Stock and Pr - GuruFocus
Ideaya Biosciences stock falls on $300M stock offering plan By Investing.com - Investing.com Australia
IDEAYA Biosciences plans $300 million stock offering By Investing.com - Investing.com Australia
Ideaya Biosciences stock falls on $300M stock offering plan - Investing.com India
IDEAYA Biosciences plans $300 million stock offering - Investing.com
IDEAYA (NASDAQ: IDYA) seeks $300M in stock and pre-funded warrants, $45M option - Stock Titan
IDEAYA Biosciences plans up to $300M stock, warrant sale, plus $45M option - Stock Titan
What IDEAYA Biosciences (IDYA)'s Darovasertib Phase 2/3 Win and Roche Deal Mean For Shareholders - Yahoo Finance
IDEAYA (IDYA) Chief Development Officer reports 297,200-share stock option holding - Stock Titan
Understanding the Setup: (IDYA) and Scalable Risk - Stock Traders Daily
1.79%
0.89%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):